Form 4: Candel Therapeutics Chief Scientific Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Francesca Barone, Chief Scientific Officer of Candel Therapeutics, sold 12,645 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On July 11, 2024, Francesca Barone, the Chief Scientific Officer of Candel Therapeutics, sold 12,645 shares of Candel Therapeutics common stock.
- The sale was executed at a price of $5.9734 per share.
- The shares were sold to cover tax withholding obligations associated with the vesting and settlement of restricted stock units, as per the company's mandatory sell-to-cover policy.
- Following the transaction, Barone directly owns 174,012 shares of Candel Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document describes a routine stock sale to cover tax obligations, which is neither particularly positive nor negative.
Industry Context
Sales to cover tax obligations are a routine part of equity compensation plans and are not necessarily indicative of a change in sentiment regarding the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 07/11/2024 | Date of stock sale transaction |
| 07/15/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.